Last edition
News about "Moberg Pharma AB"
Moberg Pharma Secures US Patent for Improved MOB-015 Dosing Regimen
Moberg Pharma secures US patent for an improved dosing regimen of MOB-015, strengthening its intellectual property portfolio through December 2041.
Moberg Pharma AB | 04/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members